GlassScriptPhysician profile
Nereida Perez
NPI 1558138024
$1,832.91
in general payments reported to CMS, 2019-2025
21 companies · $1,052 in 2025
The $1,052 reported for 2025 was more than what 87% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $781 · 2025: $1,052.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,833.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,832.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $544.04 | 2024-2025 | Ozempic, Wegovy, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $228.77 | 2024-2025 | Airsupra, Breztri, Farxiga |
| Otsuka America Pharmaceutical, INC. | $211.45 | 2024-2025 | Rexulti |
| Lilly USA, LLC | $159.15 | 2024-2025 | Zepbound, Mounjaro, Jardiance |
| Dexcom, INC. | $137.65 | 2024 | Dexcom G6 Transmitter |
| Harmony Biosciences LLC | $97.57 | 2025 | |
| Glaxosmithkline, LLC. | $64.15 | 2024-2025 | Trelegy Ellipta |
| Gilead Sciences, INC. | $53.34 | 2025 | |
| Amgen INC. | $44.65 | 2024 | Repatha, Otezla |
| Pfizer INC. | $41.05 | 2024-2025 | |
| Abiomed | $36.49 | 2024 | Impella |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.61 | 2025 | Jardiance |
| Abbvie INC. | $27.07 | 2024 | |
| Acella Pharmaceuticals, LLC | $23.84 | 2024 | NP Thyroid 60 |
| Nevro Corp. | $21.36 | 2024 | Senza |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $21.16 | 2025 | |
| Tandem Diabetes Care, INC. | $20.88 | 2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Sequel Med Tech, LLC | $20.10 | 2025 | Twiist |
| Ascensia Diabetes Care US INC. | $17.95 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $16.56 | 2024 | |
| Medline Industries LP | $14.07 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nereida Perez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.